West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
245.86
+1.51 (0.62%)
At close: Mar 6, 2026, 4:00 PM EST
245.86
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:20 PM EST
WST Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for WST stock have an average target of 319.43, with a low estimate of 265 and a high estimate of 355. The average target predicts an increase of 29.92% from the current stock price of 245.86.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for WST stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $325 → $265 | Hold | Maintains | $325 → $265 | +7.78% | Feb 13, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $390 → $320 | Buy | Maintains | $390 → $320 | +30.16% | Feb 3, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $285 | Hold | Initiates | $285 | +15.92% | Dec 2, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $350 | Strong Buy | Initiates | $350 | +42.36% | Oct 29, 2025 |
| Barclays | Barclays | Hold Maintains $275 → $325 | Hold | Maintains | $275 → $325 | +32.19% | Oct 27, 2025 |
Financial Forecast
Revenue This Year
3.28B
from 3.07B
Increased by 6.73%
Revenue Next Year
3.48B
from 3.28B
Increased by 6.07%
EPS This Year
8.10
from 6.79
Increased by 19.32%
EPS Next Year
8.99
from 8.10
Increased by 11.01%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.4B | 3.7B | |||
| Avg | 3.3B | 3.5B | |||
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.8% | 12.1% | |||
| Avg | 6.7% | 6.1% | |||
| Low | 2.9% | 0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.62 | 9.76 | |||
| Avg | 8.10 | 8.99 | |||
| Low | 7.74 | 8.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 27.0% | 20.5% | |||
| Avg | 19.3% | 11.0% | |||
| Low | 14.0% | 1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.